VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cellsBINDRA, Ranjit S; VASSELLI, James R; STEARMAN, Robert et al.Cancer research (Baltimore). 2002, Vol 62, Num 11, pp 3014-3019, issn 0008-5472Article

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialWELLS, Samuel A; ROBINSON, Bruce G; READ, Jessica et al.Journal of clinical oncology. 2012, Vol 30, Num 2, pp 134-141, issn 0732-183X, 8 p.Article

Inhibition of tumor metastasis by a growth factor receptor bound protein 2 src homology 2 domain-binding antagonistGIUBEFLINO, Alessio; YANG GAO; LEE, Sunmin et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6012-6016, issn 0008-5472, 5 p.Article

Cancers as wounds that do not heal : Differences and similarities between renal regeneration/repair and renal cell carcinomaRISS, Joseph; KHANNA, Chand; LIMING YANG et al.Cancer research (Baltimore). 2006, Vol 66, Num 14, pp 7216-7224, issn 0008-5472, 9 p.Article

Von Hippel-Lindau Tumor Suppressor Gene Loss in Renal Cell Carcinoma Promotes Oncogenic Epidermal Growth Factor Receptor Signaling via Akt-1 and MEK-1. CommentaryLEE, S. Justin; LATTOUF, Jean-Baptiste; XANTHOPOULOS, Julie et al.European urology. 2008, Vol 54, Num 4, pp 845-854, issn 0302-2838, 10 p.Article

The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidineALLEMAN, Wade G; TABIOS, Ray L; CHANDRAMOULI, Gadisetti V. R et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 7011-7021, issn 1078-0432, 11 p.Article